West Pharmaceutical Services holds the cleaner structural position, with profitability as the main driver and valuation adding further support. Encompass Health still has the edge on valuation, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels.
Most of the separation is still concentrated in profitability. The overall score gap is 17 points in favour of West Pharmaceutical Services, Inc..
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
The strongest overlap appears in capital structure and margin consistency.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
West Pharmaceutical Services, Inc. occupies the cheaper side of the setup map, although Encompass Health Corporation still holds the stronger structural profile.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The clearest distance comes from a stronger profitability profile.
Absolute pricing still looks more supportive for Encompass Health, with a forward P/E that is 12.2 turns lower there.
The profitability lead is clear, but pricing and valuation still pull in the other direction — the result holds, but not without friction.
Break down the EHC vs WST comparison across all dimensions with the full interactive tool.
Explore how EHC and WST each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.